Total Payments
$208,248
2024 Payments
$53,434
Companies
51
Transactions
785
Payment Breakdown by Category
Other$131,877 (63.3%)
Travel$22,138 (10.6%)
Food & Beverage$20,636 (9.9%)
Research$16,785 (8.1%)
Consulting$16,600 (8.0%)
Education$212.32 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $130,677 | 67 | 62.8% |
| Travel and Lodging | $22,138 | 67 | 10.6% |
| Food and Beverage | $20,636 | 632 | 9.9% |
| Unspecified | $16,785 | 7 | 8.1% |
| Consulting Fee | $16,600 | 5 | 8.0% |
| Honoraria | $1,200 | 1 | 0.6% |
| Education | $212.32 | 6 | 0.1% |
Payments by Type
General
$191,463
778 transactions
Research
$16,785
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $134,801 | 194 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $21,725 | 22 | $0 (2024) |
| Eli Lilly and Company | $16,574 | 11 | $0 (2021) |
| Eton Pharmaceuticals, Inc. | $11,738 | 5 | $0 (2024) |
| ABBVIE INC. | $7,031 | 91 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $5,454 | 13 | $0 (2022) |
| PFIZER INC. | $1,771 | 29 | $0 (2024) |
| Insulet Corporation | $1,392 | 97 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $720.76 | 41 | $0 (2024) |
| Azurity Pharmaceuticals, Inc. | $686.12 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,434 | 105 | Novo Nordisk Inc ($24,055) |
| 2023 | $20,964 | 106 | Novo Nordisk Inc ($15,356) |
| 2022 | $60,995 | 138 | Novo Nordisk Inc ($51,220) |
| 2021 | $17,184 | 107 | Novo Nordisk Inc ($14,205) |
| 2020 | $10,437 | 59 | Novo Nordisk Inc ($8,321) |
| 2019 | $16,554 | 68 | Eli Lilly and Company ($15,206) |
| 2018 | $8,775 | 110 | Novo Nordisk Inc ($4,891) |
| 2017 | $19,904 | 92 | Novo Nordisk Inc ($16,753) |
All Payment Transactions
785 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: Growth Hormone | ||||||
| 12/04/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,932.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Obesity | ||||||
| 12/03/2024 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,031.25 | General |
| Category: Growth Hormone | ||||||
| 12/03/2024 | Novo Nordisk Inc | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $602.63 | General |
| Category: Growth Hormone | ||||||
| 12/03/2024 | Novo Nordisk Inc | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $558.89 | General |
| Category: Growth Hormone | ||||||
| 12/03/2024 | Novo Nordisk Inc | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $168.60 | General |
| Category: Growth Hormone | ||||||
| 12/03/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $119.60 | General |
| Category: Growth Hormone | ||||||
| 11/21/2024 | Tolmar, Inc. | FENSOLVI (Drug) | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,932.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Growth Hormone | ||||||
| 11/12/2024 | Novo Nordisk Inc | Sogroya (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,218.75 | General |
| Category: Growth Hormone | ||||||
| 11/12/2024 | Novo Nordisk Inc | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $872.90 | General |
| Category: Growth Hormone | ||||||
| 11/12/2024 | Novo Nordisk Inc | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $807.17 | General |
| Category: Growth Hormone | ||||||
| 11/12/2024 | Novo Nordisk Inc | Sogroya (Biological) | Travel and Lodging | In-kind items and services | $251.90 | General |
| Category: Growth Hormone | ||||||
| 11/12/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $120.75 | General |
| Category: Growth Hormone | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Rare Disease | ||||||
| 11/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $123.16 | General |
| Category: Automated insulin delivery system | ||||||
| 11/07/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,866.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/07/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $480.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/07/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 11/05/2024 | Azurity Pharmaceuticals, Inc. | TRIPTODUR (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,932.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/24/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: ENDOCRINOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND COMPARISON OF LY900014 TO HUMALOG WITH AN OPEN-LABEL POSTPRANDIAL LY900014 TREATMENT GROUP IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES | Eli Lilly and Company | $15,368 | 4 |
About Dr. Quentin Vanmeter, MD
Dr. Quentin Vanmeter, MD is a Pediatric Endocrinology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245265453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Quentin Vanmeter, MD has received a total of $208,248 in payments from pharmaceutical and medical device companies, with $53,434 received in 2024. These payments were reported across 785 transactions from 51 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($130,677).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Atlanta, GA
- Active Since 07/12/2006
- Last Updated 04/04/2012
- Taxonomy Code 2080P0205X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1245265453
Products in Payments
- Norditropin (Biological) $72,307
- Sogroya (Biological) $39,112
- TZIELD (Biological) $21,725
- Norditropin (Drug) $21,283
- ALKINDI (Drug) $11,594
- Lupron (Drug) $4,820
- FENSOLVI (Drug) $4,708
- LUPRON DEPOT (Drug) $1,837
- GENOTROPIN (Drug) $1,771
- Omnipod (Device) $1,392
- HUMALOG (Drug) $1,083
- ELIGARD (Drug) $890.39
- TRIPTODUR (Drug) $543.22
- GVOKE PFS (Drug) $478.68
- iLet Bionic Pancreas (Device) $444.98
- SKYTROFA (Drug) $427.75
- ZOMACTON (Drug) $367.15
- Triptodur (Drug) $323.83
- HUMATROPE (Drug) $295.48
- Lupron Depot (Drug) $273.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Atlanta
Eric Felner, Md, MD
Pediatric Endocrinology — Payments: $163,296
Pediatric Endocrinology $163,296
Stephen Anderson, Md, MD
Pediatric Endocrinology — Payments: $2,712
Pediatric Endocrinology $2,712
Andrew Muir, Md, MD
Pediatric Endocrinology — Payments: $2,692
Pediatric Endocrinology $2,692
Rajeev Thirunagari
Pediatric Endocrinology — Payments: $1,861
Pediatric Endocrinology $1,861
Kristina Cossen, Md, MD
Pediatric Endocrinology — Payments: $1,539
Pediatric Endocrinology $1,539
Marjorie Golekoh, Md, MD
Pediatric Endocrinology — Payments: $1,533
Pediatric Endocrinology $1,533